Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block vs Local Infiltration for Pain After Appendectomy in Children
NCT04969133Completed
- Sponsor
- CHU de Besançon
- Start
- Jul 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levobupivacaine in postoperative pain (2 arms), sponsored by CHU de Besançon. Primary endpoint: Cumulative dose of nalbuphine in the first 24 hours post surgery. Started Jul 2021; status: completed.
02
Drugs
levobupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04969133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04969133.